Literature DB >> 28054228

Polymicrobial pneumococcal bacteraemia: a case-control study.

I Grau1, C Ardanuy2, M H Schulze3, J Liñares2, R Pallares4.   

Abstract

Polymicrobial bacteraemia involving Streptococcus pneumoniae and other bacteria (e.g. Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Haemophilus influenza, viridans streptococci, Salmonella spp.) occurred in 3.4% of our pneumococcal bacteraemia cases. Compared with 308 controls (monomicrobial bacteraemia), the 77 polymicrobial cases included more males (83 vs 62%, p = 0.001), had serious underlying diseases (100 vs 80%, p < 0.001), abdominal infection (18 vs 5%, p < 0.001), nosocomial infection (33 vs 8%, p < 0.001), shock (40 vs 13%, p < 0.001), and higher mortality (52 vs 18%, p < 0.001). Clinicians must be aware that some patients with pneumococcal bacteraemia may have other bacteria in their blood, which would confer higher mortality and may lead to inappropriate or incomplete antibiotic therapy.

Entities:  

Mesh:

Year:  2017        PMID: 28054228     DOI: 10.1007/s10096-016-2885-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype.

Authors:  Raquel Sá-Leão; Francisco Pinto; Sandra Aguiar; Sónia Nunes; João A Carriço; Nelson Frazão; Natacha Gonçalves-Sousa; José Melo-Cristino; Hermínia de Lencastre; Mário Ramirez
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

2.  [Polymicrobial endocarditis caused by Streptococcus pneumoniae and Streptococcus pyogenes in a heroin addict carrying the human immunodeficiency virus].

Authors:  A Sánchez Porto; M González Serrano; F Brav Ladrón de Guevara; E Rojas
Journal:  Med Clin (Barc)       Date:  1991-01-26       Impact factor: 1.725

3.  Smoking and alcohol abuse are the most preventable risk factors for invasive pneumonia and other pneumococcal infections.

Authors:  Imma Grau; Carmen Ardanuy; Laura Calatayud; Marco H Schulze; Josefina Liñares; Roman Pallares
Journal:  Int J Infect Dis       Date:  2014-05-19       Impact factor: 3.623

4.  Impact of bacterial coinfection on clinical outcomes in pneumococcal pneumonia.

Authors:  S Kumagai; T Ishida; H Tachibana; Y Ito; A Ito; T Hashimoto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-10       Impact factor: 3.267

5.  Polymicrobial bacteremic pneumonia: report of three cases caused by Staphylococcus aureus and Streptococcus pneumoniae.

Authors:  R A Goodwin; S M Opal
Journal:  Am Rev Respir Dis       Date:  1987-10

6.  Pneumococcal peritonitis in adult patients: report of 64 cases with special reference to emergence of antibiotic resistance.

Authors:  O Capdevila; R Pallares; I Grau; F Tubau; J Liñares; J Ariza; F Gudiol
Journal:  Arch Intern Med       Date:  2001-07-23

Review 7.  Polymicrobial bacteremia in the late 1980s: predictors of outcome and review of the literature.

Authors:  G S Cooper; D S Havlir; D M Shlaes; R A Salata
Journal:  Medicine (Baltimore)       Date:  1990-03       Impact factor: 1.889

8.  Polymicrobial Staphylococcus aureus bacteremia: Frequency, distinguishing characteristics and outcome.

Authors:  Riad Khatib; Mamta Sharma; Leonard B Johnson; Kathleen Riederer; Laurence Briski
Journal:  Diagn Microbiol Infect Dis       Date:  2016-08-12       Impact factor: 2.803

9.  Bacteriology of hospital-acquired pneumonia.

Authors:  J G Bartlett; P O'Keefe; F P Tally; T J Louie; S L Gorbach
Journal:  Arch Intern Med       Date:  1986-05

Review 10.  Polymicrobial bacteremia: clinical and microbiologic patterns.

Authors:  A G Reuben; D M Musher; R J Hamill; I Broucke
Journal:  Rev Infect Dis       Date:  1989 Mar-Apr
View more
  2 in total

Review 1.  Molecular Methodologies for Improved Polymicrobial Sepsis Diagnosis.

Authors:  Mariam Doualeh; Matthew Payne; Edward Litton; Edward Raby; Andrew Currie
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

2.  Pseudomonas aeruginosa Protease IV Exacerbates Pneumococcal Pneumonia and Systemic Disease.

Authors:  Jessica L Bradshaw; Armando R Caballero; Michael A Bierdeman; Kristen V Adams; Haley R Pipkins; Aihua Tang; Richard J O'Callaghan; Larry S McDaniel
Journal:  mSphere       Date:  2018-05-02       Impact factor: 4.389

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.